Lv4
520 积分 2025-10-11 加入
Abstract PD10-02: A randomised phase II trial of single fraction or multi-fraction SABR (stereotactic ablative body radiotherapy) with atezolizumab in patients with advanced triple negative breast cancer (AZTEC trial)
9天前
已关闭
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
22天前
已完结
Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
23天前
已完结
Time to abandon single-site irradiation for inducing abscopal effects
26天前
已完结
Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer
27天前
已完结
Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
1个月前
已完结
Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
1个月前
已完结
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
1个月前
已完结
Neoadjuvant radioimmunotherapy synergy in triple-negative breast cancer: Is microenvironment-guided patient selection on the horizon?
1个月前
已完结
Radiation therapy and immunotherapy in breast cancer treatment: preliminary data and perspectives
1个月前
已完结
皖公网安备34019202002308
